General form of registration statement for all companies including face-amount certificate companies

Prepaid Expenses and Other Current Assets (Details) - Schedule of prepaid expenses

v3.23.2
Prepaid Expenses and Other Current Assets (Details) - Schedule of prepaid expenses - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Prepaid Expenses [Abstract]      
Litigation receivable (Note 11) $ 754,217 $ 1,027,292 $ 1,937,693
Research and development expense tax credit receivable 322,129 546,563 644,513
Professional fees 438,501 310,017 [1] 294,577 [1]
Value-added tax receivable 9,734 48,774 24,411
Taxes 25,634 25,634 25,634
Other   49,755
Total $ 1,550,215 $ 1,958,280 $ 2,976,583
[1] In the previously filed Annual Report on Form 10-K for the year ended December 31, 2021, the Insurance line item above included $213,974 of expenses related to Oxford agreements for our CBR Pharma subsidiary. In the current year, those same expenses are grouped into the Professional fees grouping. As such, for comparative purposes, that amount has been moved from the Insurance grouping to the Professional fees grouping for the 2021 period.